J Cancer Prev.
2019 Mar;24(1):63-63. 10.15430/JCP.2019.24.1.63.
Corrigendum: Anti-growth Effects of Imatinib and GNF5 via Regulation of Skp2 in Human Hepatocellular Carcinoma Cells
- Affiliations
-
- 1China-US (Henan) Hormel Cancer Institute, Henan, China.
- 2Department of Animal Science, College of Ecology and Environment Science, Kyungpook National University, Sangju, Korea.
- 3Department of Dental Hygiene, College of Science and Technology, Kyungpook National University, Sangju, Korea. rim0804@knu.ac.kr
- KMID: 2447445
- DOI: http://doi.org/10.15430/JCP.2019.24.1.63
Abstract
- The original version of this article contained error in the Figure 1.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Anti-growth Effects of Imatinib and GNF5 via Regulation of Skp2 in Human Hepatocellular Carcinoma Cells
- Imatinib and GNF-5 Exhibit an Inhibitory Effect on Growth of Hepatocellar Carcinoma Cells by Downregulating S-phase Kinase-associated Protein 2
- MicroRNA-186 targets SKP2 to induce p27(Kip1)-mediated pituitary tumor cell cycle deregulation and modulate cell proliferation
- The Effect of Rosiglitazone on the Cell Proliferation and the Expressions of p27 and Skp2 in Helicobacter pylori Infected Human Gastric Epithelial Cells
- Anti-proliferative Effect of 15,16-Dihydrotanshinone I Through Cell Cycle Arrest and the Regulation of AMP-activated Protein Kinase/Akt/mTOR and Mitogen-activated Protein Kinase Signaling Pathway in Human Hepatocellular Carcinoma Cells
